Jaguar Health, Inc.
About Jaguar Health, Inc.
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $11.5M
- Net income
- -$53.6M
- Total assets
- $38.3M
- Market cap
- $2.0M
Source: SEC EDGAR · updated Jun 8, 2026
- Market cap
- $2.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 13, 2015
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Jaguar Health, Inc..